General issues related to rare disease and orphan drugs.
2026 · 3rd Quarter (July 1 - Sep 30)
INOVIO PHARMACEUTICALS
Filed by TODD STRATEGY GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 27, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- TODD STRATEGY GROUP
- Client
- INOVIO PHARMACEUTICALS
- Filing UUID
- d22a0f7a-4b62-4a7f-a0bb-90d5e9f6b0b5
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.